TMDX logo

TMDX
Transmedics Group Inc

6,709
Mkt Cap
$3.89B
Volume
479,286.00
52W High
$156.00
52W Low
$82.62
PE Ratio
23.82
TMDX Fundamentals
Price
$115.68
Prev Close
$113.36
Open
$114.02
50D MA
$123.81
Beta
1.34
Avg. Volume
1.05M
EPS (Annual)
$4.87
P/B
8.38
Rev/Employee
$674,269.49
$4,962.69
Loading...
Loading...
News
all
press releases
TransMedics Group, Inc. $TMDX Position Lifted by Baillie Gifford & Co.
Baillie Gifford & Co. grew its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 21.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by Brokerages
TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, Marketbeat...
MarketBeat·2d ago
News Placeholder
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·19d ago
News Placeholder
TransMedics Group (NASDAQ:TMDX) Shares Down 4.5% - Here's What Happened
TransMedics Group (NASDAQ:TMDX) Shares Down 4.5% - Here's Why...
MarketBeat·20d ago
News Placeholder
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX rides OCS adoption and strong fourth-quarter results, but margin pressure raises questions for investors.
Zacks·20d ago
News Placeholder
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push
TransMedics Group (NASDAQ:TMDX) CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company's strategy, clinical trial planning, and operational initiatives during a fireside chat hosted by Oppenheimer senior medical devices analyst Suraj Kalia. Expanding TransMedics' role...
MarketBeat·23d ago
News Placeholder
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) have received a consensus rating of "Moderate Buy" from the twelve brokerages that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and seven have given a buy rating...
MarketBeat·27d ago
News Placeholder
TransMedics Group (NASDAQ:TMDX) Trading Down 7.4% - What's Next?
TransMedics Group (NASDAQ:TMDX) Trading Down 7.4% - Should You Sell...
MarketBeat·27d ago
News Placeholder
17,165 Shares in TransMedics Group, Inc. $TMDX Acquired by Kensington Investment Counsel LLC
Kensington Investment Counsel LLC bought a new position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·28d ago
News Placeholder
TransMedics Group, Inc. $TMDX Shares Bought by Fred Alger Management LLC
Fred Alger Management LLC boosted its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 303.8% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·29d ago
<
1
2
...
>

Latest TMDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.